Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
323
-
Total 13F shares, excl. options
-
80.7M
-
Shares change
-
+37.8K
-
Total reported value, excl. options
-
$3.8B
-
Value change
-
+$1.75M
-
Put/Call ratio
-
2.37
-
Number of buys
-
2
-
Number of sells
-
-9
-
Price
-
$47.08
Significant Holders of RESMED INC - Common Stock (RMD) as of Q4 2013
344 filings reported holding RMD - RESMED INC - Common Stock as of Q4 2013.
RESMED INC - Common Stock (RMD) has 323 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.7M shares
of 146M outstanding shares and own 55.08% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.61M shares), Capital Research Global Investors (8.24M shares), State Street Corp (4.56M shares), COMMONWEALTH BANK OF AUSTRALIA (4.42M shares), BlackRock Fund Advisors (4.12M shares), BlackRock Institutional Trust Company, N.A. (3.89M shares), FMR LLC (3.86M shares), Bank of New York Mellon Corp (3.37M shares), NORTHERN TRUST CORP (1.5M shares), and APG All Pensions Group NV (1.44M shares).
This table shows the top 323 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.